57- Sachdeva A. WederAB: nocturnal sodium excretion, blood pressure dipping and sodium sen-
sitivity. Hypertension. 2006;48:527–33. - Salles GF, Cardoso CR, Pereira VS, Fiszman R, Muxfeldt ES. Prognostic significance of a
reduced glomerular filtration rate and interaction with microalbuminuria in resistant hyper-
tension: a cohort study. J Hypertens. 2011;29:2014–23. - Salles G, Cardoso C, Fiszman R, Muxfeldt E. Prognostic importance of baseline and serial
changes in microalbuminuria in patients with resistant hypertension. Atherosclerosis.
2011;216:199–204. - de Beus E, Bots ML, van Zuilen AD, Wetzels JF, Blankestijn PJ, MASTERPLAN Study
Group. Prevalence of apparent therapy-resistant hypertension and its effect on outcome in
patients with chronic kidney disease. Hypertension. 2015;66(5):998–1005. - Palmer BF. Renal dysfunction complicating the treatment of hypertension. N Engl J Med.
2002;347(16):1256–61. - Christen AI, Armentano RL, Miranda A, Graf S, Santana DB, Zócalo Y, et al. Arterial wall
structure and dynamics in type 2 diabetes mellitus methodological aspects and pathophysio-
logical findings. Curr Diabetes Rev. 2010;6:367–77. - Weir MR, Townsend RR, Fink JC, Teal V, Anderson C, Appel L, et al. Hemodynamic corre-
lates of proteinuria in chronic kidney disease. Clin J Am Soc Nephrol. 2011;6:2403–10. - Sanders PW. Vascular consequences of dietary salt intake. Am J Physiol Renal Physiol.
2009;297:F237–43. - Sarnak MJ, Levey AS, Schoolwerth AC, Coresh J, Culleton B, Hamm LL, et al. Kidney dis-
ease as a risk factor for development of cardiovascular disease: a statement from the American
Heart Association Councils on Kidney in Cardiovascular Disease, High Blood Pressure
Research, Clinical Cardiology, and Epidemiology and Prevention. Hypertension. 2003;
42(5):1050–65. - Agarwal R, Light RP. GFR, proteinuria and circadian blood pressure. Nephrol Dial Transplant.
2009;24(8):2400–6. - De Zeeuw D, Remuzzi G, Parving HH, Keane WF, Zhang Z, Shahinfar S, et al. Albuminuria,
a therapeutic target for cardiovascular protection in type 2 diabetic patients with nephropathy.
Circulation. 2004;110(8):921–7. - Hemmelgarn BR, Manns BJ, Lloyd A, James MT, Klarenbach S, Quinn RR, Wiebe N, Tonelli
M. Alberta kidney disease network. Relation between kidney function, proteinuria, and
adverse outcomes. JAMA. 2010;303(5):423–9. - De Nicola L, Minutolo R, Bellizzi V, Zoccali C, Cianciaruso B, Andreucci VE, et al.
Achievement of target blood pressure levels in chronic kidney disease: a salty question? Am
J Kidney Dis. 2004;43(5):782–95. - De Nicola L, Minutolo R, Gallo C, Zoccali C, Cianciaruso B, Conte M, et al. Management of
hypertension in chronic kidney disease: the Italian multicentric study. J Nephrol. 2005;
18(4):397–404. - De Nicola L, Conte G, Chiodini P, D’Angiò P, Donnarumma G, Minutolo R. Interaction
between phosphorus and parathyroid hormone in non-dialysis CKD patients under nephrol-
ogy care. J Nephrol. 2014;27(1):57–63. - De Nicola L, Provenzano M, Chiodini P, Borrelli S, Garofalo C, Pacilio M, et al. Independent
role of underlying kidney disease on renal prognosis of patients with chronic kidney disease
under nephrology care. PLoS One. 2015;10(5):e0127071. - Borrelli S, De Nicola L, Stanzione G, Conte G, Minutolo R. Resistant hypertension in non-
dialysis chronic kidney disease. Int J Hypertens. 2013;2013:929183. - Koomans HA, Roose JC, Mees EJD, Delawi IMK. Sodium balance in renal failure: a
comparison with normal subjects under extremes of sodium intake. Hypertension. 1985;
7(5):714–21. - Pimenta E, Gaddam KK, Oparil S, Aban I, Husain S, Dell’Italia LJ, Calhoun DA. Effects of
dietary sodium reduction on blood pressure in subjects with resistant hypertension: results
from a randomized trial. Hypertension. 2009;54(3):475–81.
4 The Importance of Ambulatory and Home Monitoring Blood Pressure in Resistant...